Cleerly LABS vs ASSURE Wearable ECG
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a highly detailed, AI-powered diagnostic analysis of coronary CT angiography (CCTA) scans. This tool is ideal for precisely quantifying atherosclerosis, characterizing plaque types, and assessing stenosis to inform personalized heart disease management and track disease progression over time.
View Cleerly LABS →Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if continuous, long-term heart rate and ECG monitoring is essential for at-risk cardiac patients in an outpatient setting. This wearable device is best suited for detecting transient cardiac events, monitoring physiological trends, and providing remote patient data to clinicians for ongoing management and timely interventions.
View ASSURE Wearable ECG →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | ASSURE Wearable ECG |
|---|---|---|
| Pricing | Varies | Unknown |
| Deployment | Cloud, On-premise | The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ASSURE Wearable ECGASSURE Wearable ECG prioritizes patient comfort and adherence with its lightweight, non-adhesive SensorFit Garment and a patient app for engagement, leading to high reported wear compliance. While Cleerly LABS offers a rich diagnostic web-based experience for clinicians, ASSURE's focus on patient-centric design for continuous monitoring provides a broader usability advantage across the care spectrum.
Clinical Value
Cleerly LABSCleerly LABS offers a more profound clinical value by providing comprehensive, AI-powered quantification and characterization of coronary plaque, stenosis, and ischemia from CCTA scans, enabling personalized and proactive heart disease management. This approach aims to fundamentally shift the paradigm of heart attack prevention, with studies demonstrating improved diagnostic accuracy and prognostic risk stratification.
Pricing & Value
Cleerly LABSCleerly LABS offers transparent pricing, including retail and discounted rates, and explicitly mentions some insurance coverage from major providers like UnitedHealthcare and Cigna, allowing for a clearer assessment of its value proposition. In contrast, ASSURE Wearable ECG requires direct contact for pricing, which makes it challenging for potential customers to evaluate its cost-effectiveness upfront.
Enterprise Readiness
Cleerly LABSCleerly LABS demonstrates superior enterprise readiness with its cloud-based (AWS) architecture, web-based application, and explicit integration capabilities with PACS, RIS, EHR, and specific radiology reporting solutions via an on-site proxy. This robust infrastructure and detailed integration support seamless deployment within complex healthcare IT environments.
Innovation
Cleerly LABSCleerly LABS showcases greater innovation by leveraging advanced AI and machine learning to non-invasively provide detailed quantification and characterization of coronary atherosclerosis, stenosis, and ischemia, and track disease progression. This technology aims to establish a new standard of care for heart attack prevention through highly personalized diagnostics.
Support & Docs
ASSURE Wearable ECGASSURE Wearable ECG provides more comprehensive and readily accessible support, including a 24/7 helpline for both patients and providers, patient handbooks, and dedicated Clinical Account Specialists who offer in-person support and EMR workflow setup. Cleerly offers general client support and documentation, but ASSURE's multi-channel and always-available support system is more robust for a patient-facing device.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | ASSURE Wearable ECG |
|---|---|---|
| Name | Cleerly LABS | ASSURE Wearable ECG |
| Company | Cleerly | Kestra Medical Technologies |
| Core Function | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | Non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients. |
| Primary Data Source | Coronary CT angiography (CCTA) images | Wearable ECG device for continuous heart rate monitoring |
| Key Analytical Capability | AI-powered CCTA image analysis; Comprehensive coronary plaque assessment (volume, type); Stenosis detection and quantification. | ASSURE Detection Algorithm with Quad Channel Processingu2122; Adaptive Patient Intelligenceu2122 for filtering motion artifacts. |
| Output/Insights | Personalized heart disease risk assessment; Tracking disease progression over time; 3D visualization of coronary arteries. | Automatic episode storage; Alert-based notifications; Physiologic trend data. |
| Clinician Platform/Integration | Integration with PACS, RIS, EHR via Cleerly Proxy. | Kestra CareStation remote patient data platform for clinician review. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and ASSURE Wearable ECG.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or ASSURE Wearable ECG
Backers
Who funded each tool's parent company.